ReviewProceedings of the National Academy of Sciences of the United States of America2010
What lies underneath: conserving the oceans' genetic resources.
Review in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 176 citations in OpenAlex.
- Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells.Frontiers in pharmacology · 2026Article
- Review
- Review
- From the Sea for the Sight: Marine Derived Products for Human Vision.Frontiers in aging neuroscience · 2022Review
- KAUST Metagenomic Analysis Platform (KMAP), enabling access to massive analytics of re-annotated metagenomic data.Scientific reports · 2021Article
- Charting a course for genetic diversity in the UN Decade of Ocean Science.Evolutionary applications · 2021Article
- Review
- Enriching cancer pharmacology with drugs of marine origin.British journal of pharmacology · 2020Review
- Review
- Corporate control and global governance of marine genetic resources.Science advances · 2018Article
- Determination of the Halogenated Skeleton Constituents of the Marine Demosponge Ianthella basta.Marine drugs · 2017Article
- Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts.Marine drugs · 2016Review
- Rapid growth of seaweed biotechnology provides opportunities for developing nations.Nature biotechnology · 2013Article
- Photoprotective bioactivity present in a unique marine bacteria collection from Portuguese deep sea hydrothermal vents.Marine drugs · 2013Article
- Biological diversity in the patent system.PloS one · 2013Article
- Article
- Tipping elements in the Arctic marine ecosystem.Ambio · 2012Article
- Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering.Marine drugs · 2011Review
- Evolving science of marine reserves: new developments and emerging research frontiers.Proceedings of the National Academy of Sciences of the United States of America · 2010Article
- From Land to Sea; Embracing a Renewable Future.Journal of biotechnology & biomaterialsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The marine realm represents 70% of the surface of the biosphere and contains a rich variety of organisms, including more than 34 of the 36 living phyla, some of which are only found in the oceans. The number of marine species used by humans is growing at unprecedented rates, including the rapid domestication of marine species for aquaculture and the discovery of natural products and genes of medical and biotechnological interest in marine biota. The rapid growth in the human appropriation of marine genetic resources (MGRs), with over 18,000 natural products and 4,900 patents associated with genes of marine organisms, with the latter growing at 12% per year, demonstrates that the use of MGRs is no longer a vision but a growing source of biotechnological and business opportunities. The diversification of the use of marine living resources by humans calls for an urgent revision of the goals and policies of marine protected areas, to include the protection of MGRs and address emerging issues like biopiracy or benefit sharing. Specific challenges are the protection of these valuable resources in international waters, where no universally accepted legal framework exists to protect and regulate the exploitation of MGRs, and the unresolved issues on patenting components of marine life. Implementing steps toward the protection of MGRs is essential to ensure their sustainable use and to support the flow of future findings of medical and biotechnological interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.